Alexander Beadle
Science Writer
Alexander Beadle has been working as a freelance science writer since 2017 and has covered the cannabis industry for Analytical Cannabis since 2018. He has also written for our sister publication, Technology Networks, and the cannabis industry consultant firm Prohibition Partners, among others. Alexander holds a Master's in Materials Chemistry from the University of St. Andrews, where he won a Chemistry Purdie scholarship, and conducted research into zeolite crystal growth mechanisms and the action of single-molecule transistors.
Latest content from Alexander Beadle
Analytical Cannabis Digest - September 2022
Download this FREE monthly resource to stay up to date with the latest developments in the cannabis industry.
VIEW
Pharmaceutical Companies Lose Billions When US States Legalize Cannabis, Study Finds
Just one US state legalizing cannabis can cost the pharmaceutical sector nearly $10 billion, according to a new, first-of-its-kind study from researchers at California Polytechnic State University and the University of New Mexico.
VIEW
Cannabis Use Jumps By 20% in Legal States, Study of Identical Twins Finds
Researchers used survey data from more than 3,400 adult twins – 111 of which were identical – to study recent trends in cannabis use and the factors affecting it.
VIEW
Cannabis Improves Sperm Quality in Rats, Study Finds
Further research into cannabis leaf extracts may one day lead to the discovery of new drugs for treating infertility, the researchers say.
VIEW
Technological Advances in Cannabis Testing
Welcome to our latest eBook, Technological Advances in Cannabis Testing, a collection of features on some of the most exciting developments in marijuana testing, penned by some of the brilliant people making them happen.
VIEW
Psychedelic Drugs Lessen Fear of Dying, Study Suggests
A psychedelic drug experience may alter people’s perspectives on death and dying in a similar way to those who have survived a near-death experience, a new study has found.
VIEW
Psilocybin and Ketamine Are Safer Than Xanax, Say US Psychiatrists
Most American psychiatrists view psilocybin and ketamine as safer drugs than alprazolam (Xanax), methamphetamine, or alcohol, according to a new survey.
VIEW
Psilocybin-Assisted Therapy Can Treat Alcohol Use Disorder, Trial Finds
The first controlled trial of psilocybin for alcohol use disorder (AUD) reports that psilocybin-assisted psychotherapy significantly reduces the occurrence of heavy drinking days in people with AUD.
VIEW
Most Cannabis Plants Contain Mitoviruses, Study Finds
In a recently published white paper, Segra scientists report that 77% of the cannabis cultivars they have screened so far tested positive for the cannabis mitovirus, CaMV1. But far from being a point of concern, the scientists suggest that this mitovirus may even be somehow beneficial to the cannabis plant.
VIEW
Curaleaf Pulls Thousands of Products Off Shelves After THC Labeling Switch
The multi-state operator has pulled tens of thousands of its products off of New York State shelves after the company switched to an unauthorized way of labeling product potency.
VIEW